LYMPHOID ENHANCER-BINDING FACTOR 1 (LEF1): AN IMMUNOHISTOCHEMICAL PREDICTIVE MARKER FOR WNT-ACTIVATED MEDULLOBLASTOMA

被引：0
|
作者：
Ranade, Manali [1 ]
Naik, Khushi [2 ,3 ]
Bapat, Prachi [1 ]
Gurav, Mamta [1 ]
Shetty, Omshree [1 ]
Shah, Aekta [2 ,3 ]
Sahay, Ayushi [2 ,3 ]
Prasad, Maya [3 ,4 ]
Singh, Vikash [3 ,5 ]
Shetty, Prakash [3 ,5 ]
Moiyadi, Aliasgar [3 ,5 ]
Dasgupta, Archya [3 ,6 ]
Chatterjee, Abhishek [3 ,6 ]
Chinnaswamy, Girish [3 ,4 ]
Gupta, Tejpal [3 ,6 ]
Epari, Sridhar [1 ]
机构：
[1] Tata Mem Hosp, Homi Bhabha Natl Inst HBNI, Tata Mem Ctr, Dept Pathol,Mol Pathol Div, Mumbai, Maharashtra, India
[2] Tata Mem Hosp, Dept Pathol, Div Mol Pathol, Mumbai, Maharashtra, India
[3] Homi Bhabha Natl Inst, Tata Mem Ctr, ACTREC, Mumbai, Maharashtra, India
[4] Tata Mem Hosp, Dept Paediat Oncol, Mumbai, Maharashtra, India
[5] Tata Mem Hosp, Dept Neurosurg, Mumbai, Maharashtra, India
[6] Tata Mem Hosp, Dept Radiat Oncol, Mumbai, Maharashtra, India
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae064.504
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MDB-55
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Overexpression of Lymphoid Enhancer-Binding Factor 1 (LEF1) in solid-pseudopapillary neoplasms of the pancreas
    Singhi, Aatur D.
    Lilo, Mhammed
    Hruban, Ralph H.
    Cressman, Kristi L.
    Fuhrer, Kimberly
    Seethala, Raja R.
    MODERN PATHOLOGY, 2014, 27 (10) : 1355 - 1363
  • [2] Lymphocyte enhancer-binding factor 1 (Lef1) inhibits terminal differentiation of osteoblasts
    Kahler, RA
    Galindo, M
    Lian, J
    Stein, GS
    van Wijnen, AJ
    Westendorf, JJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 97 (05) : 969 - 983
  • [3] Lymphoid Enhancer-binding Factor-1 (LEF1) Interacts with the DNA-binding Domain of the Vitamin D Receptor
    Luderer, Hilary F.
    Gori, Francesca
    Demay, Marie B.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (21) : 18444 - 18451
  • [4] Evidence for association of lymphoid enhancer-binding factor-1 (LEF1) with the number of functional and inverted teats in pigs
    Tetzlaff, S.
    Jonas, E.
    Phatsara, C.
    Murani, E.
    Ponsuksili, S.
    Schellander, K.
    Wimmers, K.
    CYTOGENETIC AND GENOME RESEARCH, 2009, 124 (02) : 139 - 146
  • [5] Immunohistochemical staining of LEF-1 is a useful marker for distinguishing WNT-activated medulloblastomas
    Depeng Wang
    Jie Gong
    Hui Zhang
    Yulu Liu
    Nannan Sun
    Xiaomeng Hao
    Kun Mu
    Diagnostic Pathology, 17
  • [6] Immunohistochemical staining of LEF-1 is a useful marker for distinguishing WNT-activated medulloblastomas
    Wang, Depeng
    Gong, Jie
    Zhang, Hui
    Liu, Yulu
    Sun, Nannan
    Hao, Xiaomeng
    Mu, Kun
    DIAGNOSTIC PATHOLOGY, 2022, 17 (01)
  • [7] High Expression of Lymphoid Enhancer-Binding Factor 1 (LEF1) Is Related to Ummutated Status of Igvh and Is an Unfavorable Prognostic Marker for Aggressive CLL Patients
    Wu, Wei
    Zhu, Huayuan
    Fu, Yuan
    Xu, Jiadai
    Shen, Wenyi
    Xu, Wei
    Liu, Peng
    Li, Jianyong
    BLOOD, 2012, 120 (21)
  • [8] Overexpression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in childhood acute lymphoblastic leukemia
    Jia, M.
    Zhao, H-Z
    Shen, H-P
    Cheng, Y-P
    Luo, Z-B
    Li, S-S
    Zhang, J-Y
    Tang, Y-M
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2015, 37 (05) : 631 - 640
  • [9] Detection of Lymphoid Enhancer-Binding Factor 1 (LEF1) by Flow Cytometry Is Not Entirely Specific for Chronic Lymphocytic Leukemia (CLL)
    Ondrejka, S. L.
    Bodo, J.
    Gay, B.
    Katanik, D. A.
    Finbar, E.
    Namiotka, F.
    Henrich, L.
    Polz, C.
    Hsi, E. D.
    MODERN PATHOLOGY, 2014, 27 : 368A - 368A
  • [10] Detection of Lymphoid Enhancer-Binding Factor 1 (LEF1) by Flow Cytometry Is Not Entirely Specific for Chronic Lymphocytic Leukemia (CLL)
    Ondrejka, S. L.
    Bodo, J.
    Gay, B.
    Katanik, D. A.
    Finbar, E.
    Namiotka, F.
    Henrich, L.
    Polz, C.
    Hsi, E. D.
    LABORATORY INVESTIGATION, 2014, 94 : 368A - 368A
12345